Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data.

Maximilian Leo Müller Ekaterina Latinova Karl Stangl Isabel Mattig Sebastian Spethmann Daniel R Messroghli Katrin Hahn Ulf Landmesser Bettina Heidecker

Published in: Journal of the American Heart Association (2024)

Treatment of ATTR-CA with tafamidis led to substantial improvements of clinical outcome. NYHA classification at treatment initiation is a reliable tool to provide patients with individualized prognostic information.

Keyphrases

heart failure
machine learning
healthcare
deep learning
type diabetes
metabolic syndrome
electronic health record
atrial fibrillation
combination therapy
social media
insulin resistance